1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of CXCL16 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of CXCL16 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CXCL16 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene decreases expression EXP 6480464 Dinitrochlorobenzene results in decreased expression of CXCL16 mRNA CTD PMID:21404309 1-naphthyl isothiocyanate increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CXCL16 mRNA CTD PMID:25380136 and PMID:30723492 1-octadec-9-enoylglycero-3-phosphate multiple interactions EXP 6480464 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid inhibits the reaction [lysophosphatidic acid results in increased expression of CXCL16 protein] CTD PMID:25822713 1-octadec-9-enoylglycero-3-phosphate increases expression EXP 6480464 lysophosphatidic acid results in increased expression of CXCL16 protein CTD PMID:25822713 17beta-estradiol multiple interactions ISO CXCL16 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CXCL16 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO CXCL16 (Homo sapiens) 6480464 Estradiol results in increased expression of CXCL16 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL16 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL16 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL16 mRNA CTD PMID:27562557 and PMID:29673856 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 4,4'-diaminodiphenylmethane increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CXCL16 mRNA CTD PMID:25380136 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression EXP 6480464 Oxazolone results in decreased expression of CXCL16 mRNA CTD PMID:21404309 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CXCL16 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CXCL16 mRNA CTD PMID:30047161 acetamide increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 acetamide results in increased expression of CXCL16 mRNA CTD PMID:31881176 acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of CXCL16 mRNA CTD PMID:18515264 aflatoxin B1 increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of CXCL16 mRNA CTD PMID:25378103 all-trans-retinoic acid increases expression ISO CXCL16 (Homo sapiens) 6480464 Tretinoin results in increased expression of CXCL16 mRNA CTD PMID:16142401 and PMID:33167477 all-trans-retinoic acid increases secretion ISO CXCL16 (Homo sapiens) 6480464 Tretinoin results in increased secretion of CXCL16 protein CTD PMID:16142401 amitrole increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Amitrole results in increased expression of CXCL16 mRNA CTD PMID:30047161 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Cxcl16 (Rattus norvegicus) 6480464 pyrazolanthrone inhibits the reaction [cypermethrin results in increased expression of CXCL16 protein] CTD PMID:35512476 antirheumatic drug decreases expression ISO CXCL16 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CXCL16 mRNA CTD PMID:24449571 arsane affects expression ISO CXCL16 (Homo sapiens) 6480464 Arsenic affects the expression of CXCL16 protein CTD PMID:24675094 arsenic atom affects expression ISO CXCL16 (Homo sapiens) 6480464 Arsenic affects the expression of CXCL16 protein CTD PMID:24675094 arsenous acid increases expression ISO CXCL16 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CXCL16 mRNA CTD PMID:25258189 benzene affects expression ISO CXCL16 (Homo sapiens) 6480464 Benzene affects the expression of CXCL16 mRNA CTD PMID:17119257 benzene increases expression ISO CXCL16 (Homo sapiens) 6480464 Benzene results in increased expression of CXCL16 mRNA CTD PMID:15929907 and PMID:19162166 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CXCL16 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO CXCL16 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CXCL16 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO CXCL16 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of CXCL16 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CXCL16 mRNA CTD PMID:22228805 and PMID:23735875 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of CXCL16 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions ISO Cxcl16 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CXCL16 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide increases expression ISO CXCL16 (Homo sapiens) 6480464 Mustard Gas results in increased expression of CXCL16 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO CXCL16 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of CXCL16 mRNA CTD PMID:31163220 bisphenol A affects expression ISO Cxcl16 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CXCL16 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CXCL16 mRNA CTD PMID:34585602 bisphenol A decreases expression ISO Cxcl16 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CXCL16 mRNA CTD PMID:30816183 more ... butan-1-ol multiple interactions ISO CXCL16 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CXCL16 mRNA CTD PMID:29432896 caffeine increases phosphorylation ISO CXCL16 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of CXCL16 protein CTD PMID:35688186 cantharidin increases expression EXP 6480464 Cantharidin results in increased expression of CXCL16 mRNA CTD PMID:36907384 carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of CXCL16 mRNA CTD PMID:25554681 chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of CXCL16 mRNA CTD PMID:21224055 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL16 mRNA CTD PMID:20938992 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with TNF protein] results in increased expression of CXCL16 mRNA CTD PMID:23103562 cobalt atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of CXCL16 mRNA CTD PMID:29507420 Cuprizon increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of CXCL16 mRNA CTD PMID:26577399 and PMID:27523638 cyclosporin A increases expression ISO CXCL16 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CXCL16 mRNA CTD PMID:20106945 cypermethrin increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 cypermethrin results in increased expression of CXCL16 mRNA and cypermethrin results in increased expression of CXCL16 protein CTD PMID:35512476 cypermethrin multiple interactions ISO Cxcl16 (Rattus norvegicus) 6480464 CXCL16 protein promotes the reaction [cypermethrin results in increased expression of IL18 mRNA] more ... CTD PMID:35512476 dexamethasone multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 diarsenic trioxide increases expression ISO CXCL16 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CXCL16 mRNA CTD PMID:25258189 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CXCL16 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of CXCL16 mRNA CTD PMID:21266533 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL16 mRNA CTD PMID:30529165 endosulfan decreases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of CXCL16 mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of CXCL16 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CXCL16 mRNA CTD PMID:30517762 flutamide decreases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CXCL16 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 furan increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 furan results in increased expression of CXCL16 mRNA CTD PMID:26194646 and PMID:27387713 gentamycin increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of CXCL16 mRNA CTD PMID:33387578 glycine betaine decreases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Betaine results in decreased expression of CXCL16 mRNA CTD PMID:26391144 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL16 mRNA CTD PMID:20938992 lidocaine increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Lidocaine results in increased expression of CXCL16 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Monocrotaline] results in increased expression of CXCL16 protein and [Monocrotaline co-treated with Lipopolysaccharides] results in decreased expression of CXCL16 protein CTD PMID:21279329 and PMID:21327618 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CXCL16 mRNA CTD PMID:26582142 monocrotaline multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Monocrotaline] results in increased expression of CXCL16 protein and [Monocrotaline co-treated with Lipopolysaccharides] results in decreased expression of CXCL16 protein CTD PMID:21279329 and PMID:21327618 N-nitrosodiethylamine multiple interactions ISO Cxcl16 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CXCL16 mRNA CTD PMID:18164116 N-nitrosodimethylamine increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of CXCL16 mRNA CTD PMID:25380136 nickel atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 nickel atom increases expression ISO CXCL16 (Homo sapiens) 6480464 Nickel results in increased expression of CXCL16 mRNA CTD PMID:25583101 nickel dichloride increases expression ISO CXCL16 (Homo sapiens) 6480464 nickel chloride results in increased expression of CXCL16 mRNA CTD PMID:26044615 nickel sulfate increases expression ISO CXCL16 (Homo sapiens) 6480464 nickel sulfate results in increased expression of CXCL16 mRNA CTD PMID:22714537 oxaliplatin increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of CXCL16 mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO Cxcl16 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL16 mRNA CTD PMID:25729387 paracetamol decreases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CXCL16 mRNA CTD PMID:33387578 paraquat increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Paraquat results in increased expression of CXCL16 mRNA CTD PMID:32680482 perfluorononanoic acid increases expression ISO CXCL16 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of CXCL16 mRNA CTD PMID:32588087 phorbol 13-acetate 12-myristate decreases expression EXP 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CXCL16 mRNA CTD PMID:22359662 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL16 mRNA] CTD PMID:22359662 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CXCL16 mRNA CTD PMID:17426115 potassium chromate increases expression ISO CXCL16 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of CXCL16 mRNA CTD PMID:22714537 propiconazole increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 propiconazole results in increased expression of CXCL16 mRNA CTD PMID:30047161 quercetin increases expression ISO CXCL16 (Homo sapiens) 6480464 Quercetin results in increased expression of CXCL16 mRNA CTD PMID:21632981 silicon dioxide multiple interactions ISO CXCL16 (Homo sapiens) 6480464 CXCL16 mRNA promotes the reaction [Silicon Dioxide results in increased expression of and results in increased secretion of CXCL8 protein] more ... CTD PMID:34653535 simvastatin decreases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Simvastatin results in decreased expression of CXCL16 mRNA CTD PMID:25055962 Soman increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Soman results in increased expression of CXCL16 mRNA CTD PMID:19281266 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CXCL16 mRNA and [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CXCL16 mRNA CTD PMID:21641980 and PMID:26378955 sulfadimethoxine increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of CXCL16 mRNA CTD PMID:30047161 sunitinib increases expression ISO CXCL16 (Homo sapiens) 6480464 Sunitinib results in increased expression of CXCL16 mRNA CTD PMID:31533062 taurocholic acid increases expression EXP 6480464 Taurocholic Acid results in increased expression of CXCL16 mRNA CTD PMID:21224055 temozolomide increases expression ISO CXCL16 (Homo sapiens) 6480464 Temozolomide results in increased expression of CXCL16 mRNA CTD PMID:31758290 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CXCL16 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CXCL16 mRNA CTD PMID:30517762 thioacetamide increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CXCL16 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CXCL16 mRNA CTD PMID:23557971 and PMID:27760801 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of CXCL16 mRNA CTD PMID:19647056 topotecan multiple interactions ISO Cxcl16 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL16 mRNA CTD PMID:25729387 topotecan increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Topotecan results in increased expression of CXCL16 mRNA CTD PMID:25729387 trichloroethene increases expression ISO Cxcl16 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of CXCL16 mRNA CTD PMID:33387578 valproic acid increases expression ISO CXCL16 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CXCL16 mRNA CTD PMID:23179753 and PMID:29154799 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of CXCL16 mRNA CTD PMID:18930951 vinclozolin affects expression ISO Cxcl16 (Rattus norvegicus) 6480464 vinclozolin affects the expression of CXCL16 mRNA CTD PMID:19015723 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA and TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 zoledronic acid increases expression ISO CXCL16 (Homo sapiens) 6480464 zoledronic acid results in increased expression of CXCL16 mRNA CTD PMID:24714768